CLSI eNews - 1 May 2008  (Plain Text Version)

Return to Graphical Version | Search back issues | Print all articles

In this issue:
Note on printing single articles: Each selected individual article will appear at the bottom of this screen...please scroll down to view/print the selected article.
 
News
 President's Message
 Leadership Conference Focus on Public Health
 Volunteer Focus
 Successful World Health Organization (WHO)/Centers for Disease Control and Prevention (CDC) International Conference on Health Laboratory Quality Systems
 Lab Guidelines & Standards
 Press Releases
Standards Status
 Vote and Deadlines
 Recently Approved Documents
 Call for Nominations
Events and Exhibits
 Upcoming Events
 Teleconferences
 Forums Training
 Upcoming Presentations
 CLSI Meetings Calendar
Participate in CLSI
 Volunteer
 Career Opportunities
 New and Sustaining Members
 Update Your Subscription


Call for Nominations

  • Evaluation of Precision Performance of Quantitative Measurement Methods (EP5-A2)
  • User Verification of Performance for Precision and Trueness (EP15-A2(e))
  • Sweat Testing:  Sample Collection and Quantitative Analysis (C34-A2)

Clinical and Laboratory Standards Institute's Area Committee on Evaluations Protocols has requested nominations to serve as subcommittee members to revise the CLSI guidelines described below.

PROJECT REVISION:
EP5-A2 to A3
, Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline

Description: 
This document provides guidance for designing an experiment to evaluate the precision performance of quantitative measurement methods; recommendations on comparing the resulting precision estimates with manufacturers’ precision performance claims and determining when such comparisons are valid; as well as manufacturers’ guidelines for establishing claims.

Specific Expertise/Work Experience Needed:

  • Manufacturers of in vitro diagnostic (IVD) devices and developers of clinical laboratory measurement methods
  • Representatives of industry
  • Statisticians
  • Chemists
  • Laboratory personnel
  • Regulatory authorities
  • Medical personnel

The deadline to submit notification of interest in serving on the subcommittee with a curriculum vitae is 31 May 2008.

Upon receipt of your statement of interest in serving on the subcommittee a disclosure of interests form will be sent to you for completion. 

Send to Donna Connery (dconnery@clsi.org) at Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, PA 19087, or via Fax at +610.688.0700.

PROJECT REVISION:
EP15-A2(e) to A3
, User Verification of Performance for Precision and Trueness; Approved Guideline

Description:
This document describes the demonstration of method precision and trueness for clinical laboratory quantitative methods utilizing a protocol designed to be completed within five working days or less.

Specific Expertise/Work Experience Needed:

  • Laboratory directors/Laboratory managers
  • Manufacturers of in vitro diagnostic (IVD) devices and developers of clinical laboratory measurement methods
  • Representatives of industry
  • Statisticians
  • Clinical chemists
  • Laboratory personnel
  • Regulatory authorities
  • Medical personnel

The deadline to submit notification of interest in serving on the subcommittee with a curriculum vitae is 31 May 2008.

Upon receipt of your statement of interest in serving on the subcommittee a disclosure of interests form will be sent to you for completion. 

Send to Donna Connery (dconnery@clsi.org) at Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, PA 19087, or via Fax at +610.688.0700.


 

Clinical and Laboratory Standards Institute's Area Committee on Clinical Chemistry and Toxicology has requested nominations to serve as subcommittee members to revise the CLSI guideline described below.

PROJECT REVISION:
C34-A2 to A3, Sweat Testing:  Sample Collection and Quantitative Analysis; Approved Guideline

Description:
This is a guideline for the performance of the sweat test for the diagnosis of cystic fibrosis.  The document addresses appropriate methods of collection and analysis, quality control, and the evaluation and reporting of test results.

Specific Expertise/Work Experience Needed:

  • Laboratory directors/Laboratory managers
  • Manufacturers of in vitro diagnostic (IVD) devices and developers of clinical laboratory measurement methods
  • Representatives of industry
  • Statisticians
  • Clinical chemists
  • Laboratory personnel
  • Regulatory authorities
  • Medical personnel.

The deadline to submit notification of interest in serving on the subcommittee with a curriculum vitae is 31 May 2008.

Upon receipt of your statement of interest in serving on the subcommittee a disclosure of interests form will be sent to you for completion. 

Send to Donna Connery (dconnery@clsi.org) at Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, PA 19087, or via Fax at +610.688.0700.


For more information or to contact us directly, please visit www.clsi.org l ©2006 Clinical and Laboratory Standards Institute